Amy Belt Raimundo joined Kaiser Permanente as a managing director in 2016. Amy brings over 20 years of experience in healthcare investing, start-up and corporate operations and hospital system consulting.
Amy has spent a dozen years in venture capital including Covidien Ventures and Advanced Technology Ventures (ATV). Immediately prior to joining KPV, Amy was the Chief Business Officer of digital health start-up Evidation Health. Amy has spent close to a decade in venture capital at Covidien Ventures and Advanced Technology Ventures (ATV). Prior to KP Ventures, she led investments in Medina Medical (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation and began her career as a management consultant for hospitals at APM/CSC Healthcare.
Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
Amy has spent a dozen years in venture capital including Covidien Ventures and Advanced Technology Ventures (ATV). Immediately prior to joining KPV, Amy was the Chief Business Officer of digital health start-up Evidation Health. Amy has spent close to a decade in venture capital at Covidien Ventures and Advanced Technology Ventures (ATV). Prior to KP Ventures, she led investments in Medina Medical (acquired by Medtronic) and Nevro Corporation (NYSE: NVRO) among others. Earlier in her career, Amy held operating roles at Guidant Corporation and began her career as a management consultant for hospitals at APM/CSC Healthcare.
Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
